To access this element change to forms mode OFF
Grant Award View - GA30172
PRECLINICAL DEVELOPMENT OF CANNABIS-DERIVED MEDICINES FOR DRUG-RESISTANT...
GA ID:
GA30172
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$747,389.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
PRECLINICAL DEVELOPMENT OF CANNABIS-DERIVED MEDICINES FOR DRUG-RESISTANT EPILEPSY
Purpose:
Intractable childhood epilepsies have a large seizure burden and are associated with reduced lifespan and developmental delays. Recent successful human trials using cannabidiol (CBD) herald great promise for the future development of cannabinoids as novel anticonvulsants. We have discovered four cannabinoids that are more potent than CBD. In this project we aim to further develop these cannabinoids, and better understand the role of the natural cannabis system in childhood epilepsy.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1161571
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES